Review of ibandronate in the treatment of metastatic bone disease: experience from phase III trials.
par Tripathy, Debu;Body, Jean-Jacques 
;Bergström, Bengt
Référence Clinical therapeutics, 26, 12, page (1947-1959)
Publication Publié, 2004-12
;Bergström, BengtRéférence Clinical therapeutics, 26, 12, page (1947-1959)
Publication Publié, 2004-12
Article révisé par les pairs
| Titre: |
|
| Auteur: | Tripathy, Debu; Body, Jean-Jacques; Bergström, Bengt |
| Informations sur la publication: | Clinical therapeutics, 26, 12, page (1947-1959) |
| Statut de publication: | Publié, 2004-12 |
| Sujet CREF: | Cancérologie |
| MeSH keywords: | Administration, Oral |
| Bone Neoplasms -- drug therapy -- secondary | |
| Breast Neoplasms -- pathology | |
| Clinical Trials, Phase III as Topic | |
| Diphosphonates -- administration & dosage -- adverse effects -- therapeutic use | |
| Humans | |
| Infusions, Intravenous | |
| Multicenter Studies as Topic | |
| Pain | |
| Poisson Distribution | |
| Randomized Controlled Trials as Topic | |
| Note générale: | Journal Article |
| Research Support, Non-U.S. Gov't | |
| Review | |
| Langue: | Anglais |
| Identificateurs: | urn:issn:0149-2918 |
| info:doi/10.1016/j.clinthera.2004.12.010 | |
| info:pii/S0149-2918(04)00080-3 | |
| info:pmid/15823760 |
